Cargando…
Intronic Polyadenylation in Acquired Cancer Drug Resistance Circumvented by Utilizing CRISPR/Cas9 with Homology-Directed Repair: The Tale of Human DNA Topoisomerase IIα
SIMPLE SUMMARY: DNA topoisomerase IIα (170 kDa, TOP2α/170) resolves nucleic acid topological entanglements by generating transient double-strand DNA breaks. TOP2α inhibitors/poisons stabilize TOP2α-DNA covalent complexes resulting in persistent DNA damage and are frequently utilized to treat a varie...
Autores principales: | Elton, Terry S., Hernandez, Victor A., Carvajal-Moreno, Jessika, Wang, Xinyi, Ipinmoroti, Deborah, Yalowich, Jack C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265003/ https://www.ncbi.nlm.nih.gov/pubmed/35804920 http://dx.doi.org/10.3390/cancers14133148 |
Ejemplares similares
-
Use of CRISPR/Cas9 with homology-directed repair to silence the human topoisomerase IIα intron-19 5’ splice site: Generation of etoposide resistance in human leukemia K562 cells
por: Hernandez, Victor A., et al.
Publicado: (2022) -
Effects of DNA topoisomerase IIα splice variants on acquired drug resistance
por: Elton, Terry S., et al.
Publicado: (2020) -
CRISPR/Cas9 and TALE: beyond cut and paste
por: Deng, Liping, et al.
Publicado: (2015) -
Experimental procedures to identify and validate specific mRNA targets of miRNAs
por: Elton, Terry S., et al.
Publicado: (2015) -
Widespread intronic polyadenylation diversifies immune cell transcriptomes
por: Singh, Irtisha, et al.
Publicado: (2018)